Vanguard Group’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22.1M | Sell |
|
|||||
|
2025
Q2 | $14.2M | Buy |
|
|||||
|
2025
Q1 | $14.4M | Sell |
|
|||||
|
2024
Q4 | $21.9M | Buy |
|
|||||
|
2024
Q3 | $13.4M | Sell |
|
|||||
|
2024
Q2 | $9.53M | Buy |
|
|||||
|
2024
Q1 | $11.5M | Buy |
|
|||||
|
2023
Q4 | $8.97M | Sell |
|
|||||
|
2023
Q3 | $7.8M | Buy |
|
|||||
|
2023
Q2 | $10.7M | Buy |
|
|||||
|
2023
Q1 | $11.3M | Buy |
|
|||||
|
2022
Q4 | $10.9M | Buy |
|
|||||
|
2022
Q3 | $11.5M | Sell |
|
|||||
|
2022
Q2 | $21.9M | Sell |
|
|||||
|
2022
Q1 | $42.1M | Buy |
|
|||||
|
2021
Q4 | $22.1M | Buy |
|
|||||
|
2021
Q3 | $22.7M | Buy |
|
|||||
|
2021
Q2 | $2.27M | Buy |
|